Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
877
-0.21%
|
$19,294
$22.91 P/Share
|
|
Jun 27
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
489
-0.41%
|
$10,758
$22.91 P/Share
|
|
Jun 27
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
590
-0.47%
|
$12,980
$22.91 P/Share
|
|
Jun 27
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
695
-0.25%
|
$15,290
$22.91 P/Share
|
|
Jun 22
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
541
-0.81%
|
$12,443
$23.41 P/Share
|
|
Jun 22
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.54%
|
$230,000
$23.32 P/Share
|
|
Jun 22
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.42%
|
$20,000
$2.06 P/Share
|
|
Jun 21
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.54%
|
$220,000
$22.97 P/Share
|
|
Jun 21
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.42%
|
$20,000
$2.06 P/Share
|
|
May 31
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
174
-0.3%
|
$4,002
$23.21 P/Share
|
|
May 31
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
392
-0.31%
|
$9,016
$23.21 P/Share
|
|
May 31
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
1,679
-0.4%
|
$38,617
$23.21 P/Share
|
|
May 31
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
337
-0.75%
|
$7,751
$23.21 P/Share
|
|
May 31
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
337
-0.77%
|
$7,751
$23.21 P/Share
|
|
May 31
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
560
-0.83%
|
$12,880
$23.21 P/Share
|
|
May 31
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
337
-0.28%
|
$7,751
$23.21 P/Share
|
|
May 31
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
504
-0.18%
|
$11,592
$23.21 P/Share
|
|
May 25
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.53%
|
$220,000
$22.33 P/Share
|
|
May 25
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.41%
|
$20,000
$2.06 P/Share
|
|
May 24
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.53%
|
$220,000
$22.14 P/Share
|
|
May 24
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.41%
|
$20,000
$2.06 P/Share
|
|
May 22
2023
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
24,973
+14.27%
|
$524,433
$21.86 P/Share
|
|
May 19
2023
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+28.57%
|
$1,100,000
$22.55 P/Share
|
|
May 18
2023
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,000
+28.56%
|
$630,000
$21.76 P/Share
|
|
May 17
2023
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,027
+40.01%
|
$630,567
$21.3 P/Share
|
|
May 17
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
33,333
-7.33%
|
$699,993
$21.04 P/Share
|
|
May 16
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
100
-0.17%
|
$1,900
$19.41 P/Share
|
|
May 16
2023
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,000
+50.0%
|
$300,000
$20.19 P/Share
|
|
May 16
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
137
-0.2%
|
$2,603
$19.41 P/Share
|
|
May 15
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
92
-0.08%
|
$1,656
$18.71 P/Share
|
|
May 15
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
72
-0.16%
|
$1,296
$18.71 P/Share
|
|
May 15
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
190
-0.04%
|
$3,420
$18.71 P/Share
|
|
May 15
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
75
-0.17%
|
$1,350
$18.71 P/Share
|
|
May 15
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
106
-0.08%
|
$1,908
$18.71 P/Share
|
|
May 15
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
125
-0.05%
|
$2,250
$18.71 P/Share
|
|
Apr 20
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.59%
|
$190,000
$19.25 P/Share
|
|
Apr 20
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.47%
|
$20,000
$2.06 P/Share
|
|
Apr 19
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
292
-0.69%
|
$5,548
$19.33 P/Share
|
|
Apr 19
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
430
-1.04%
|
$8,170
$19.33 P/Share
|
|
Apr 19
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.59%
|
$190,000
$19.47 P/Share
|
|
Apr 19
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.47%
|
$20,000
$2.06 P/Share
|
|
Apr 14
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
215
-0.52%
|
$4,515
$21.05 P/Share
|
|
Apr 06
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
1,545
-1.31%
|
$30,900
$20.03 P/Share
|
|
Apr 06
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,093
-0.77%
|
$41,860
$20.03 P/Share
|
|
Apr 06
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
739
-1.72%
|
$14,780
$20.03 P/Share
|
|
Apr 06
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
771
-1.82%
|
$15,420
$20.03 P/Share
|
|
Apr 06
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
3,214
-0.71%
|
$64,280
$20.03 P/Share
|
|
Apr 06
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
1,101
-0.9%
|
$22,020
$20.03 P/Share
|
|
Mar 31
2023
|
Roderick De Greef President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,740
+9.55%
|
-
|
|
Mar 29
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
521
-0.44%
|
$10,420
$20.62 P/Share
|